Cathay Capital

Things are moving fast at FuturMaster! Only three months after its acquisition by Sagard NewGen alongside Cathay Capital, the leading provider of SaaS solution for Supply Chain Planning FuturMaster has acquired 100% of its counterpart PlaniSense. This operation aims to combine the complementary technologies and business expertise of the two companies to offer a unified, end-to-end supply chain planning solution. FuturMaster continues its internationalization, with a presence in France, the UK, China and Singapore, with the ambition of opening offices in the USA in 2025. Congratulations to Nazim NACHI and Yacine Zeroual on this ambitious strategic partnership! Read more 👉 Cc: Jérémie Falzone Maximillian Gairard Marc Lin

How can we reconcile economic growth and environmental imperatives?   🤝The effects of climate change and the digitization of both the economy and the way we communicate will have a significant impact on our future, and taking both into account is crucial.   ♻️Digital technologies are now key to achieving a durable and efficient energy transition to fight climate change, and tapping into innovative, AI-powered solutions will tremendously help reduce greenhouse gas emissions.   ⚡As such, the fast rollout of technological advancements that are easy to adopt by consumers is essential to continue to demonstrate their relevance.   💡Solar and wind energy, heat pumps, and decentralized power generation are all successful initiatives whose effects we are already witnessing—and in turn, further deployment will give way to more affordable and new financing and resale systems, be they over-the-counter or via energy-as-a-service models. Read Matthieu van der Elst's op-ed below to know more ⤵️

✨We’re hiring✨ Join our team as a VC Platform Associate (VIE) and get an immersive experience in the heart of Silicon Valley’s innovation hub! In this role, you will work hand in hand with the Head of US Ecosystem to optimize daily operations and uphold Cathay Innovation’s reputation as a supportive, insightful player. Your daily routine: 🌍 Kicking off the day with early calls to our European colleagues. 📝 Taking detailed notes in meetings and summarizing key outcomes and action points. 💡 Crafting impactful presentations for corporate opportunities.  🚀 Engaging with startups to explore innovative solutions to solve corporate challenges. 🤝 Collaborating with our experienced team to bring Silicon Valley insights to global corporates. Apply now and join our dynamic and purpose-driven San Francisco team! https://lnkd.in/eN9d8J6E

  🔎 Go Behind the Term Sheet of our investment in Bioptimus, leading its recent $41M Series A.   Imagine an AI foundation model that had a holistic understanding of complex biology — connecting the dots between modalities and scales — from molecules to cells, tissues and whole organisms. This would unleash untold biotechnological research and innovation and its precisely what Bioptimus aims to do.   As co-founder and CEO Jean-Philippe Vert says, think of them as “the GPT of biology”.   A few highlights:   🤖 1 | Bioptimus was incubated by Owkin — the French AI biotech leader which Cathay Innovation is proud to have backed since 2017. This isn’t just a good story, it gives them a unique data edge (essential in the world of FMs)…   🙌 2 | The team’s credentials speak for themselves, with a founding team of big tech and biopharma veterans hailing from the likes of Google, Amazon, Owkin…   ✨ 3 | Significant milestones have already been reached with the release of the largest AI foundation model for pathology and the best is yet to come…   After investing in their seed round less than a year ago, we were thrilled to lead the Series A — a testament to Bioptimus’ potential in harnessing state-of-the-art technologies to unlock unprecedented possibilities for a wide variety of applications, from early drug design to patient diagnostics and beyond.   📖 Read more from Jacky Abitbol and Paul Pouyanne on the journey ⤵️ 

✨Another inspiring night at our Paris office for our AI for Finance event, hosted as part of the AI Action Week! 💡From Kayrros’ innovative alternative data vision, to a deep dive into isahit’s data annotation, and Alma’s AI-driven risk modeling to end things on a sharp note—the exchanges were as insightful as our speakers’ expertise. Renaud Dumora & Charles-Albert Lehalle wrapped things up with an outstanding fireside chat, shedding light on AI’s impact on banking and the evolving FinTech landscape.  👏 A huge thank you to Augustin Prate, Philippe Coup-Jambet-Jambet, Louis C. and our numerous attendees—your engagement made this event truly special! #AIinFinance #AIActionWeek #FinanceInnovation #AITransformation #TechMeetsFinance Cc : Denis Barrier Jacky Abitbol Charles-Albert Lehalle Bruno Delahaye Emanuele De Leonardis Romain Dufourcq Louis Conchon Joy Boublil (李悦)

Cathay Capital portfolio company Parkview Dental Partners has acquired two Lifetime Smiles Dental Care practices in Sarasota and St. Petersburg, Florida. This strategic acquisition, which follows the acquisition of Tampa-based Breezy Dental, expands Parkview's presence in the Gulf Coast region and reflects its commitment to supporting innovative and patient-centric dental care providers. We're excited to partner with Dr. Christopher Donato and his talented team as they continue to deliver exceptional dental services to their communities. Congratulations to everyone involved in this successful transaction! More here ⬇️

🌍 Reindustrialization & Private Equity: A Winning Bet?   How is private equity supporting companies industries in the era of re-industrialization, nearshoring, and sustainability? Do these trends open new strategic opportunities for investors? As part of #IPEMCannes2025, our Managing Director Benoit SERINGE joined an expert panel alongside Jean-Francois Beaudoin (Latour Capital), Haskell Crocker (WAVE Equity Partners), and Barbara Fernandez Giron, CESGA.   Moderated by Patricia Pascual Ramsay, this discussion provided insights on changing global supply chains, strategic industrial shifts and the role of private markets in driving the convergence of re-industrialization and sustainability. Benoit highlighted some success stories from Cathay Capital’s portfolio in helping companies producing in Europe to scale, become champions in their sector and sell all over the world : “Our main thesis and obsession is: how can we help companies scale and achieve leadership positions globally, building on the assets of each region in terms of R&D and innovation, industry and supply chain, with an ecosystem mindset”.   The healthcare sector provides many examples of leading companies addressing global markets with factories in Europe. Were mentioned companies such as Biose Industrie, Marle Group and Moon Surgical : “Marle has five factories in France, their R&D and industrial is clearly in Europe, but they are selling their hip and knee implants all over the world. Same for Biose that we exited last year: they work with big pharma clients from US, Europe and Asia, but most of their research is in Aurillac and they have doubled the size of their production facilities there over the last years, with our support”   #PrivateEquity #Reindustrialization #Sustainability #MidCap #Investments #CathayCapital

✨ Cathay Innovation-backed Nabla is featured in Sopra Steria and France Digitale's latest mapping of French AI startups. The report highlights the booming sector of digital health accounting for 13% of all startups, making it the most represented. Nabla is a game-changing developer of AI-powered Nabla Copilot, which generates automated clinical notes, significantly reducing time-consuming administrative tasks and allowing caregivers to allot more time to their patients. 🧑⚕️ Over 45 000 practitioners have already adopted Nabla’s solution! Just a year ago, we led Nabla’s $24M Series B round, further developing our portfolio of health-focused companies that drive positive change. Check out Les Echos’s story to know more ⤵️

Maximilien Levesque, CEO and Co-founder of Cathay Innovation-backed AQEMIA, sat down with BFM Business to discuss AI and quantum physics’ role in revolutionizing drug discovery.   Maximilien and Emmanuelle Martiano Rolland built AQEMIA to harness innovation around: 🔬 A unique approach that combines generative AI and physics-based modeling to design therapeutic molecules without relying on experimental data. 💊 A platform has already showcased a huge potential, with major breakthroughs in oncology and a strategic partnership with Sanofi. 🌍 A global expansion, starting with a new London office opening this month and accelerating the development of innovative treatments to patients, all over the world.   Cathay Innovation led AQEMIA’s latest $38 million funding round, bringing its cumulated funding to over $100 million.   Watch the replay:

We are happy to be attending IPEM Cannes from January 28 to 30. Come meet us at Stand E105 to discuss the future of investing, explore new opportunities, and exchange insights! 📅 Don’t miss our panel discussion on Thursday, January 30, at 3:15 PM in Conference Room 1, on the topic: "Investing in Europe: Re-industrialization" We'll explore key trends driving Europe's industrial resurgence and the opportunities ahead. See you in Cannes! Cc: Edouard Moinet Matthieu van der Elst Daniel BALMISSE Benoit SERINGE Margot Briole Timothée Marin